NUVL - Nuvalent, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-1.48
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$133.09
DETAILS
HIGH:
$155.00
LOW:
$105.00
MEDIAN:
$132.00
CONSENSUS:
$133.09
UPSIDE:
26.81%
Market Cap:
7.63B
Volume:
508,302
Avg Volume:
598,768
52 Week Range:
55.535-113.015
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.32
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
162
IPO Date:
2021-07-29
EPS (TTM):
-3.93
P/E Ratio:
-19.94
Revenue (TTM):
N/A
Total Assets:
1.14B
Total Debt:
N/A
Cash & Equiv:
145.69M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-25.8%
Debt/Equity:
N/A
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-30 | $-1.70 | $-1.39 | -22.3% | — | — | — |
| 2025-08-07 | $-1.31 | $-1.27 | -3.1% | — | — | — |
| 2025-05-08 | $-1.18 | $-1.14 | -3.5% | — | — | — |
| 2025-02-27 | $-1.05 | $-1.04 | -1.0% | — | — | — |
| 2024-11-12 | $-1.28 | $-0.93 | -37.0% | — | — | — |
| 2024-08-08 | $-0.88 | $-0.76 | -15.8% | — | — | — |
| 2024-05-09 | $-0.69 | $-0.67 | -3.0% | — | — | — |
| 2024-02-27 | $-0.62 | $-0.59 | -5.1% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (260.76M) | (126.22M) | (81.85M) | (46.34M) | (14.56M) | (11.81M) |
| EPS | -3.93 | -2.17 | -1.65 | -2.13 | -0.64 | -0.24 |
| Total Assets | 1.14B | 732.38M | 482.46M | 293.82M | 10.65M | 3.32M |
| Total Debt | 0 | 0 | 0 | 0 | 2.23M | 2.17M |
| Cash & Equivalents | 145.69M | 335.39M | 241.81M | 68.53M | 10.33M | 3.02M |
| Operating Cash Flow | (185.06M) | (99.74M) | (64.97M) | (40.00M) | (14.95M) | (9.64M) |
| Free Cash Flow | (185.06M) | (99.74M) | (64.97M) | (40.00M) | (14.95M) | (9.64M) |
| FCF per Share | -2.79 | -1.71 | -1.31 | -1.84 | -0.65 | -0.20 |
| Book Value | 1.07B | 700.56M | 462.98M | 285.04M | (31.32M) | (17.26M) |
| Cash & ST Investments | 1.12B | 719.90M | 472.16M | 288.11M | 10.33M | 3.02M |
| ROC Equity | -0.24 | -0.18 | -0.18 | -0.16 | N/A | N/A |